Allspring Global Investments’s Korro Bio KRRO Stock Holding History

Allspring Global Investments’s Portfolio KRRO Stock Details KRRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-517	Closed	-$54K	–	2818
2022 Q1	$54K	Buy	+517	New	+$98.8K	﹤0.01%	2837

Other funds holding KRRO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Allspring Global Investments's KRRO Position: Q2 2022 in Review

Allspring Global Investments sold out of Korro Bio (KRRO) in Q2 2022, closing a stake of 517 shares — an estimated $54K sold.

Allspring Global Investments first reported a position in KRRO in Q1 2022 and held it in 1 quarter. The position peaked at $54K in Q1 2022. 58 funds tracked by Wall St. Rank hold KRRO as of Q2 2022.

Allspring Global Investments reported no remaining Korro Bio position as of Q2 2022 after selling out during the quarter.
Allspring Global Investments sold 517 Korro Bio shares in Q2 2022, an estimated $54K.
Allspring Global Investments first reported a position in Korro Bio in Q1 2022 and held it in 1 quarter.
Allspring Global Investments's Korro Bio position peaked at $54K in Q1 2022.
58 funds tracked by Wall St. Rank held Korro Bio as of Q2 2022.

Based on Allspring Global Investments's 13F filing for Q2 2022, filed 25 Jul 2022.